Antagonists of Dsg2 for treatment of cancer

Details for Australian Patent Application No. 2010299626 (hide)

Owner ASCLEPIUMM LIMITED

Inventors Chen, Min-Che

Agent Marks & Clerk Australia

Pub. Number AU-A-2010299626

PCT Pub. Number WO2011/036440

Priority 0916686.9 23.09.09 GB

Filing date 22 September 2010

Wipo publication date 31 March 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

19 April 2012 PCT application entered the National Phase

  PCT publication WO2011/036440 Priority application(s): WO2011/036440

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010299630-Heparin cofactor II fragments with antiinflammatory and anti-coagulant activity

2010299624-Wellbore servicing fluid compositions and use thereof